Boceprevir Telaprevir published presentations and documents on DocSlides.
for Patients with Prior Failure to PEG + RIB. PRO...
ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR ...
RESPOND-2. Phase . 3. Treatment. . Experienced. ...
Department of Medicine. University of Toronto. Co...
Marie-Louise Vachon, MD, . MSc. Division of . Inf...
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
thalassaemia. . Where . are we now?. Telaprevir ....
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Todd S. Wills, MD. SPNS HCV Treatment Expansion I...
Mark S. Sulkowski, MD. Medical Director, Viral He...
JournalofHepatologyvol.56 Keywords:HCV;HepattitisC...
Naïve GT-1. ADVANCE (Study 108). Phase . 3. Trea...
versus . Telaprevir. . with PR in GT1 . ATTAIN ...
Naïve GT-1. ILLUMINATE (Study 111). Phase . 3. T...
with PEG + RBV in Genotype 1. SPRINT. -1. Phase ....
SPRINT-2. Phase 3, Treatment . Naive. Treatment. ...
BID versus q8 in Treatment Naïve GT-1. OPTIMIZE ...
Regina . Ubaldi. -Rosen, CRNP. ELLAH NOTA, CRNP. ...
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
OPTIMIZE (. Study . C211). Phase . 3. Treatment. ...
Créteil, France. Paris, 30 January 2012. Triple t...
Mark Sulkowski, . MD. Professor of Medicine. Medic...
really necessary?. Peter . Ferenci. Medical Univer...
in Hepatitis C . Paris . Februari. 2012. Ola . We...
SPRINT. -1. Phase . 2. Treatment. . Naïve. Kwo. ...
Copyright © 2024 DocSlides. All Rights Reserved